Detection of circulating prostate-specific antigen-positive cells in patients with prostate cancer by flow cytometry and reverse transcription polymerase chain reaction

British Journal of Cancer

Volumn 74, Issue 3, 1996, Pages 400-405

  Fadlon, E J ^a   Rees, R C ^a   McIntyre, C ^a   Sharrard, R M ^a   Lawry, J ^a   Hamdy, F C ^b  

^a UNIVERSITY OF SHEFFIELD   (United Kingdom)

^b FREEMAN HOSPITAL   (United Kingdom)

Author keywords

Flow cytometry; Micrometastases; Prostate cancer; Prostate specific antigen; Reverse transcriptase polymerase chain reaction

Indexed keywords

MESSENGER RNA; PROSTATE SPECIFIC ANTIGEN;

ARTICLE; BLOOD; CLINICAL ARTICLE; CONTROLLED STUDY; FEMALE; FLOW CYTOMETRY; HUMAN; HUMAN CELL; HUMAN TISSUE; MALE; METASTASIS; MONOCYTE; PHAGOCYTOSIS; PRIORITY JOURNAL; PROSTATE CANCER; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION; TUMOR CELL;

EID: 0030056574     PISSN: 00070920     EISSN: None     Source Type: Journal    
DOI: 10.1038/bjc.1996.372     Document Type: Article

References (20)

1. CAMA C, OLSSON CA, RAFFO AJ, PERLMAN H, BUTTYAN R, O'TOOLE K, MCMAHON D, BENSON MC AND KATZ AE. (1995). Molecular staging of prostate cancer. II. A comparison of the application of an enhanced reverse transcriptase polymerase chain reaction assay for prostate specific antigen verus prostate specific membrane antigen. 153, 1373-1378.
2. CHODAK GW, THISTED RA, GERBER GS, JOHANSSON J-E, ADOLFSSON J, JONES GW, CHISHOLM GD, MOSKOVITZ B, LIVNE PM AND WARNER J. (1994). Outcome following conservative management of patients with clinically localized prostate cancer. N. Eng. J. Med., 330, 242-248.
3. CHOMCZYNSKI P AND SACCHI N. (1987). Single-step method of RNA isolation by acid guanidium thiocyanate-phenol-chloroform extraction. Anal. Biochem., 162, 156-159.
4. ENGELL HC. (1995). Cancer cells in the circulating blood. Clinical study on occurrence of cancer cells in peripheral blood and in venous blood draining tumour area at operation. Acta Chir. Scand. (suppl), 201, 1-70.
5. EPSTEIN JI, CARMICHAEL MJ, PIZOV G AND WALSH PC. (1993). Influence of capsular penetration on progression following radical prostatectomy: a study of 196 cases with long-term follow-up. J. Urol., 150, 135-141.
6. FIDLER IJ. (1970). Metastasis: Quantitative analysis of distribution and fate of tumour emboli labelled with 125I-5-iodo-2′-deoxyuridine. J. Natl Cancer Inst., 45, 773-782.
7. FIDLER IJ AND KRIPKE ML. (1977). Metastasis results from preexisting variant cells within a malignant tumor. Science, 197, 893-895.
8. FLEMING C, WASSON JH, ALBERTSEN PC, BARRY MJ AND WENNBERG JE. FOR THE PROSTATE PATIENT OUTCOMES RESEARCH TEAM. (1993). A decision analysis of alternative treatment strategies for clinically localised prostate cancer. JAMA, 269, 2650-2658.
9. HAMDY FC, LAWRY J, ANDERSON JB, PARSONS MA, REES RC AND WILLIAMS JL. (1992). Circulating prostate specific antigen-positive cells correlate with metastatic prostate cancer. Br. J. Urol., 69, 196-392.
10. ISRAELI RS, MILLER WH, SU SL, POWELL T, FAIR WR, SAMADI DS, HURYK RF, DEBLASIO A, EDWARDS ET, WISE GJ AND HESTON WDW. (1994). Sensitive nested reverse transcription polymerase chain reaction detection of circulating prostatic tumor cells: comparison of prostate-specific membrane antigen and prostate-specific antigen-based assays. Cancer Res., 54, 6306-6310.
11. ISRAELI RS, MILLER WH, SU SL, SAMEDI DS, POWELL CT, HESTON WDW AND FAIR WR. (1995). Sensitive detection of prostatic hematogenous tumor cell dissemination using prostate specific antigen and prostate specific membrane-derived primers in the polymerase chain reaction. J. Urol., 153, 573 577.
12. KATZ AE, OLSSON CA, RAFFO AJ, CAMA C, PERLMAN H, SEAMAN E, O'TOOLE KM, MCMAHON D, BENSON MC AND BUTTYAN R. (1994). Molecular staging of prostate cancer with the use of an enhanced reverse transcriptase-PCR assay. Urology 43, 765-774.
13. LU-YAO GL, MCLERRAN D, WASSON J AND WENNBERG JE FOR THE PROSTATE PATIENT OUTCOMES RESEARCH TEAM. (1993). An assessment of radical prostatectomy. JAMA, 269, 2633-2636.
14. MORENO JG, CROCE CM, FISCHER R, MONNE M, VIHKO P, MULHOLLAND SG AND GOMELLA LG. (1992). Detection of hematogenous micrometastasis in patients with prostate cancer. Cancer Res., 52, 6110-6112.
15. OFFICE OF POPULATION, CENSUSES AND SURVEYS. (1993). Cancer Statistics. Registrations 1987. Series MB1 No. 20. HMSO: London.
16. POSTE G AND FIDLER IJ. (1980). The pathogenesis of cancer metastasis. Nature, 283, 139-146.
17. RIEGMAN PHJ, VLIESTRA RJ, VAN DER KORPLT JAGM, ROMJIN JC AND TRAPMAN J. (1989). Characterization of the prostate-specific antigen gene: a novel human kallikrein-like gene. Biochem. Biophys. Res. Commun., 159, 95-102.
18. SCHWARTZ R, WALK A, TOOMES H AND SCHIRRMACHER V. (1985). Assay for the determination of human carcinoma cells in circulating blood. J. Cancer Res. Clin. Oncol., 109, 122 129.
19. SMITH MR, BIGGAR S AND HUSSAIN M. (1995). Prostate specific antigen messenger RNA is expressed in non-prostate cells: implications for detection of micrometastases. Cancer Res., 55, 2640-2644.
20. WARREN S AND GATES O. (1936). Fate of intravenously injected tumor cells. Am. J. Cancer. 27, 485-492.